Pre-Eclampsia Clinical Trial
Official title:
Scaling Up an Integrated Approach to Improve Delivery Care and Reduce Maternal and Perinatal Mortality in North Guatemala With Stepped Wedge Design
"¡Que Vivan las Madres!: Venga a tener su parto al CAP" (QVLM) is a guatemalan quasi-experimental study that has been performed from January 2014 to January 2017 by the Epidemiological Research Center in Sexual and Reproductive Health (CIESAR) in Guatemala in coordination with PRONTO International and University of San Francisco, California. This project has been financed by Grands Challenges Canada' "Save Lives at Birth, A Grand Challenge for Development" partnership that includes USAID, Norwegian ministry of foreign affairs, Bill&Melinda Gates foundation, UKaid. This project has applied a stepped wedge design (SWD) over 6 zones or clusters. Each one of the zones contains from 4 to 6 communities, each one with the presence of one second level health facility (known in Spanish as CAP, Centro de Atención Permanente). These health centers are the next level in attention after home, traditional and empirical attention. Communities around the selected health centers are mostly rural and have the worst maternal health indicators in the country. These health centers are expected to have enough equipment and personnel to attend the deliveries that occur in their communities. This study was performed in Huehuetenango and Alta Verapaz districts in north Guatemala. Each one with 3 zones for a total of 6 zones. The study follows a Stepped Wedge Design, in which all 6 zones are eventually intervened, but at different regular periods of time (each period is 4 months long). This project applies a package of 3 simultaneous interventions in each zone with the purpose of increasing institutional deliveries and improving deliveries attention in public health centers. This intervention plan has been implemented in a pilot study reported in (Kestler et. al, 2013).
Individual delivery data has been collected in site from health centers records. Thus, the
study does not depend on official data from the ministry of health. Not only is MOH data
hard to obtain, it also may not contain the details we are interested in that are put by
hand by doctors and nurses in clinic histories. In order to get uniform data that fits the
study needs, a parallel monitoring process has been set up. Data for mortality and morbidity
events that occured in communities during the study is limited. We don't have the community
counterpart of our indicators. Government data of perinatal deaths in community may be
obtained with 1 or 2 years of delay, however there may be an underreporting of such events.
Likewise, there is no data source for maternal morbidity in community deliveries since
community practice is usually not documented nor reported.
The concept of perinatal mortality used in this study is not the standard concept that
includes death from 28th gestational week to 7 days after birth. The perinatal mortality
outcome in this study takes into account only deaths that occur during care in health
centers (approximately 48 hours since birth). This is intentional since the aim of this
study is to improve clinics' skilled delivery care, thereferore it is concerned on reducing
the newborn deaths that occur during care given in site. Along this study, the focus is in
these subset of perinatal deaths.
The APGAR measure 1 minute and 5 minutes after birth, and the reported procedures for the
newborn are used to identify cases of perinatal morbidity.
This study is targetted to the low level health centers in Huehuetenango and Alta Verapaz.
This includes 33 health centers. This is a fixed number of health centers and there is no
control of the patients that got treated at the health centers. This is the reason why there
is no sample size assessment. The selection of the health centers was limited by the
definition of CAP (second level health facilities according to local definition) and the
amount of patients that received the intervention by attending their deliveries in health
centers can not be controlled.
Having data on all vaginal and uncomplicated deliveries that occur in health centers, the
analysis can be done by individual cases and also by aggregating data in time periods. Also,
analysis methodology of trials with stepped wedge design has been developed in the last
years. A generalized mixed model for a multilevel and longitudinal analysis is going to be
used in order to account for different sources of variability within and between health
centers and times. So far (April 2017) we have done preliminary analysis this way and are
confortable with this methodology selection.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03299777 -
Correlation Between Changes in Liver Stiffness and Preeclampsia as Shown by Fibroscan
|
N/A | |
Completed |
NCT03650790 -
C1q/TNF-related Protein 9 (CTRP 9) Level in Preeclamptic Obese and Non-obese Pregnancies
|
N/A | |
Recruiting |
NCT03605511 -
TTP and aHUS in Complicated Pregnancies
|
||
Not yet recruiting |
NCT03302260 -
Identifying Methods for Postpartum Reduction of Vascular Events: Pilot Randomized Controlled Trial
|
N/A | |
Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
Completed |
NCT01911494 -
Community Level Interventions for Pre-eclampsia
|
N/A | |
Terminated |
NCT02025426 -
Phenylephrine Versus Ephedrine in Pre-eclampsia
|
Phase 4 | |
Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
Active, not recruiting |
NCT02031393 -
Establishing First Trimester Markers for the Identification of High Risk Twin
|
N/A | |
Terminated |
NCT00141310 -
Sildenafil Citrate for the Treatment of Established Pre-Eclampsia
|
Phase 2 | |
Completed |
NCT00157521 -
L-Arginine in Pre-Eclampsia
|
Phase 3 | |
Completed |
NCT04795154 -
Prenatal Yoga as Complementary Therapy of Preeclampsia
|
N/A | |
Completed |
NCT00004399 -
Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia
|
N/A | |
Completed |
NCT00005207 -
Renin and Prorenin in Pregnancy
|
N/A | |
Recruiting |
NCT04551807 -
Natural Versus Programmed Frozen Embryo Transfer (NatPro)
|
Phase 3 | |
Terminated |
NCT04092829 -
Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer
|
N/A | |
Recruiting |
NCT06067906 -
Weight Loss Following an Episode of Pre-eclampsia Using a Dissociated or Hypocaloric Diet in Overweight or Obese Patients
|
N/A | |
Recruiting |
NCT06317467 -
Role of Anti-C1q Autoantibodies in Pregnancy
|
||
Completed |
NCT02218931 -
ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes
|
N/A | |
Active, not recruiting |
NCT04484766 -
Preeclampsia Associated Vascular Aging
|